NO20091970L - Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion - Google Patents

Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion

Info

Publication number: NO20091970L
Authority: NO; Norway
Prior art keywords: quinazolin; pyrrol; piperazin; indol; dione
Prior art date: 2006-10-20

Application number

NO20091970A

Other languages

English (en)

Norwegian (no)

Inventor

Piotr Karpinski

Paul Allen Sutton

Dimitris Papoutsakis

Stephanie Monnier

Elias Ndzie

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-20

Filing date

2009-05-20

Publication date

2009-05-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38921707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091970(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-20 Application filed by Novartis Ag filed Critical Novartis Ag

2009-05-20 Publication of NO20091970L publication Critical patent/NO20091970L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20091970A 2006-10-20 2009-05-20 Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion NO20091970L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US85338406P	2006-10-20	2006-10-20
PCT/US2007/022241 WO2008051440A1 (fr)	2006-10-20	2007-10-18	Modifications cristallines

Publications (1)

Publication Number	Publication Date
NO20091970L true NO20091970L (no)	2009-05-20

Family

ID=38921707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091970A NO20091970L (no)	2006-10-20	2009-05-20	Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion

Country Status (23)

Country	Link
US (1)	US8865897B2 (fr)
EP (1)	EP2102195A1 (fr)
JP (1)	JP5302199B2 (fr)
KR (1)	KR20090073231A (fr)
CN (2)	CN103265533A (fr)
AR (1)	AR063491A1 (fr)
AU (1)	AU2007309558B2 (fr)
BR (1)	BRPI0717461A2 (fr)
CA (1)	CA2666965A1 (fr)
CL (1)	CL2007003006A1 (fr)
EC (1)	ECSP099344A (fr)
IL (1)	IL197962A (fr)
MA (1)	MA30886B1 (fr)
MX (1)	MX2009004048A (fr)
MY (1)	MY158026A (fr)
NO (1)	NO20091970L (fr)
NZ (1)	NZ576241A (fr)
PE (1)	PE20081133A1 (fr)
RU (1)	RU2481341C2 (fr)
TN (1)	TN2009000147A1 (fr)
TW (1)	TWI399374B (fr)
WO (1)	WO2008051440A1 (fr)
ZA (1)	ZA200902048B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010520879A (ja) *	2007-03-09	2010-06-17	ノバルティスアーゲー	３−（１ｈ−インドール−３−イル）−４−［２−（４−メチル−ピペラジン−１−イル）−キナゾリン−４−イル］−ピロール−２，５−ジオンの塩
US9017528B2 (en)	2011-04-14	2015-04-28	Tel Nexx, Inc.	Electro chemical deposition and replenishment apparatus
US9005409B2 (en)	2011-04-14	2015-04-14	Tel Nexx, Inc.	Electro chemical deposition and replenishment apparatus
US9303329B2 (en)	2013-11-11	2016-04-05	Tel Nexx, Inc.	Electrochemical deposition apparatus with remote catholyte fluid management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20020544A1 (es) *	2000-11-07	2002-07-30	Novartis Ag	Derivados de indolilmaleimida
GB0504203D0 (en) *	2005-03-01	2005-04-06	Novartis Ag	Organic compounds
MX2009013431A (es)	2007-06-18	2010-01-15	Sanofi Aventis	Derivados de pirrol como antagonistas de p2y12.

2007
- 2007-10-18 PE PE2007001411A patent/PE20081133A1/es not_active Application Discontinuation
- 2007-10-18 BR BRPI0717461-6A2A patent/BRPI0717461A2/pt not_active IP Right Cessation
- 2007-10-18 CA CA002666965A patent/CA2666965A1/fr not_active Abandoned
- 2007-10-18 AU AU2007309558A patent/AU2007309558B2/en not_active Ceased
- 2007-10-18 MY MYPI20091403A patent/MY158026A/en unknown
- 2007-10-18 WO PCT/US2007/022241 patent/WO2008051440A1/fr not_active Ceased
- 2007-10-18 NZ NZ576241A patent/NZ576241A/en not_active IP Right Cessation
- 2007-10-18 CN CN2013101739586A patent/CN103265533A/zh active Pending
- 2007-10-18 EP EP07839661A patent/EP2102195A1/fr not_active Withdrawn
- 2007-10-18 CN CN2007800383914A patent/CN101522664B/zh not_active Expired - Fee Related
- 2007-10-18 KR KR1020097010201A patent/KR20090073231A/ko not_active Ceased
- 2007-10-18 JP JP2009533377A patent/JP5302199B2/ja not_active Expired - Fee Related
- 2007-10-18 AR ARP070104622A patent/AR063491A1/es unknown
- 2007-10-18 MX MX2009004048A patent/MX2009004048A/es active IP Right Grant
- 2007-10-18 US US12/445,371 patent/US8865897B2/en not_active Expired - Fee Related
- 2007-10-18 RU RU2009118816/04A patent/RU2481341C2/ru not_active IP Right Cessation
- 2007-10-19 CL CL200703006A patent/CL2007003006A1/es unknown
- 2007-10-19 TW TW096139386A patent/TWI399374B/zh not_active IP Right Cessation
2009
- 2009-03-24 ZA ZA200902048A patent/ZA200902048B/xx unknown
- 2009-04-05 IL IL197962A patent/IL197962A/en not_active IP Right Cessation
- 2009-04-17 TN TNP2009000147A patent/TN2009000147A1/fr unknown
- 2009-05-13 MA MA31867A patent/MA30886B1/fr unknown
- 2009-05-19 EC EC2009009344A patent/ECSP099344A/es unknown
- 2009-05-20 NO NO20091970A patent/NO20091970L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101522664B (zh)	2013-06-12
CN101522664A (zh)	2009-09-02
CL2007003006A1 (es)	2008-05-23
US8865897B2 (en)	2014-10-21
AU2007309558B2 (en)	2012-05-24
JP2010506927A (ja)	2010-03-04
RU2009118816A (ru)	2010-11-27
BRPI0717461A2 (pt)	2013-10-08
CA2666965A1 (fr)	2008-05-02
TW200829572A (en)	2008-07-16
CN103265533A (zh)	2013-08-28
WO2008051440A1 (fr)	2008-05-02
AU2007309558A1 (en)	2008-05-02
KR20090073231A (ko)	2009-07-02
TN2009000147A1 (en)	2010-10-18
AR063491A1 (es)	2009-01-28
MY158026A (en)	2016-08-30
RU2481341C2 (ru)	2013-05-10
ECSP099344A (es)	2009-06-30
EP2102195A1 (fr)	2009-09-23
TWI399374B (zh)	2013-06-21
NZ576241A (en)	2012-05-25
PE20081133A1 (es)	2008-09-16
IL197962A (en)	2013-08-29
US20100041884A1 (en)	2010-02-18
IL197962A0 (en)	2009-12-24
ZA200902048B (en)	2010-01-27
MA30886B1 (fr)	2009-11-02
JP5302199B2 (ja)	2013-10-02
MX2009004048A (es)	2009-04-27

Similar Documents

Publication	Publication Date	Title
CY1119624T1 (el)	2018-04-04	Κρυσταλλικες μορφες του 4-μεθυλο-ν-[3-(4-μεθυλ-ιμιδαζολ-1-υλ)-5-τριφθορομεθυλο-φαινυλο] -3 -(4-πυριδιν-3-υλ-πυριμιδιν-2-υλαμινο)-βενζαμιδιου
MX2009002229A (es)	2009-03-16	Benzotriazoles como moduladores de cinasas.
NO20076066L (no)	2008-01-07	Oksadiazolderivater som DGAT-inhibitorer
EA201001005A1 (ru)	2011-02-28	Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы
EA201070395A1 (ru)	2010-10-29	Ингибиторы polo-подобных киназ
EA201000093A1 (ru)	2010-06-30	Производные пиридазинона
DOP2013000072A (es)	2013-08-15	((r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino.
EA200970019A1 (ru)	2009-08-28	Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил]пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
NO20091299L (no)	2009-04-29	Substituerte sulfonamidderivater
BR112015007937A2 (pt)	2017-07-04	formas cristalinas de um inibidor de fator xia
TW200722421A (en)	2007-06-16	Azole derivatives as inhibitors of lipases and phospholipases
ATE542800T1 (de)	2012-02-15	Kinasehemmer und ihre anwendungsverfahren
NO20082096L (no)	2008-05-29	Azaindol-2-karboksamidderivativer
HK1222396A1 (zh)	2017-06-30	作为选择性蛋白质激酶抑制剂之苯并咪唑衍生物
EA201100872A1 (ru)	2012-01-30	Производные хиназолинамида
EA201000618A1 (ru)	2011-04-29	5-цианотиенопиридины для лечения опухолей
NO20091970L (no)	2009-05-20	Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion
NO20082214L (no)	2008-07-31	1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
WO2008104473A3 (fr)	2008-11-06	Inhibiteurs de kinase et procédés d'utilisation de ces derniers
ATE553106T1 (de)	2012-04-15	Heteroarylpyrrolopyridinone als kinaseinhibitoren
NO20083269L (no)	2008-09-19	Prosess for a anvende krystallinsk orlistatmetoder
ATE487721T1 (de)	2010-11-15	Triaza-benzoäeüazulenderivate zur behandlung von tumoren
WO2007087419A3 (fr)	2007-09-13	Hétérocyclyl-1,3-dihydro-indol-2-ones insaturées et substituées à 3-5 éléments et leurs dérivés en tant qu'inhibiteurs de kinase
ATE449776T1 (de)	2009-12-15	Pyrroloä2,3-cüpyridinderivate
WO2006037032A3 (fr)	2006-07-20	Promedicaments d'inhibiteurs de la proteine tyrosine kinase

Legal Events

Date	Code	Title	Description
2016-05-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application